Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 83
13
Diseases
13
Unique genes
0.351
Avg. similarity score
Emery dreifuss muscular dystrophy
Most-connected disease (10 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Emery dreifuss muscular dystrophy
Severe lipodystrophic laminopathy
Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome
Lipoatrophic diabetes mellitus
Malouf syndrome
Emery-dreifuss muscular dystrophy
Mandibuloacral dysostosis
Mandibuloacral dysplasia
Restrictive dermopathy
Werner syndrome
dilated cardiomyopathy 1A
mandibuloacral dysplasia progeroid syndrome
arrhythmogenic right ventricular dysplasia 5
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Emery dreifuss muscular dystrophy | 10 | 10 | 1 |
| Severe lipodystrophic laminopathy | 10 | 10 | 1 |
| Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome | 8 | 8 | 1 |
| Lipoatrophic diabetes mellitus | 7 | 7 | 1 |
| Malouf syndrome | 6 | 6 | 1 |
| Emery-dreifuss muscular dystrophy | 5 | 5 | 7 |
| Mandibuloacral dysostosis | 5 | 5 | 3 |
| Mandibuloacral dysplasia | 5 | 5 | 4 |
| Restrictive dermopathy | 5 | 5 | 2 |
| Werner syndrome | 5 | 5 | 4 |
| dilated cardiomyopathy 1A | 5 | 5 | 1 |
| mandibuloacral dysplasia progeroid syndrome | 2 | 2 | 1 |
| arrhythmogenic right ventricular dysplasia 5 | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| LMNA | 11 / 13 | dilated cardiomyopathy 1A, Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome, Emery dreifuss muscular dystrophy, Emery-dreifuss muscular dystrophy and 7 more |
| MTX2 | 3 / 13 | Mandibuloacral dysostosis, Mandibuloacral dysplasia, mandibuloacral dysplasia progeroid syndrome |
| ZMPSTE24 | 3 / 13 | Mandibuloacral dysostosis, Mandibuloacral dysplasia, Restrictive dermopathy |
| TMEM43 | 2 / 13 | arrhythmogenic right ventricular dysplasia 5, Emery-dreifuss muscular dystrophy |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Cytoskeleton in muscle cells | KEGG | 6 / 232 | 23.9× | 7.46e-8 | 5.05e-6 ✓ sig. |
| Nuclear Envelope Breakdown | Reactome | 2 / 9 | 205× | 3.88e-5 | 1.03e-3 ✓ sig. |
| Depolymerisation of the Nuclear Lamina | Reactome | 2 / 15 | 123× | 1.13e-4 | 2.47e-3 ✓ sig. |
| Initiation of Nuclear Envelope (NE) Reformation | Reactome | 2 / 19 | 97.2× | 1.83e-4 | 3.66e-3 ✓ sig. |
| Signaling by SCF-KIT | Reactome | 2 / 37 | 49.9× | 7.05e-4 | 1.04e-2 ✓ sig. |
| Proteoglycans in cancer | KEGG | 3 / 204 | 13.6× | 1.22e-3 | 1.57e-2 ✓ sig. |
| Extra-nuclear estrogen signaling | Reactome | 2 / 58 | 31.9× | 1.73e-3 | 2.05e-2 ✓ sig. |
| Constitutive Signaling by Aberrant PI3K in Cancer | Reactome | 2 / 75 | 24.6× | 2.87e-3 | 2.98e-2 ✓ sig. |
| Breakdown of the nuclear lamina | Reactome | 1 / 3 | 308× | 3.24e-3 | 3.26e-2 ✓ sig. |
| Arrhythmogenic right ventricular cardiomyopathy | KEGG | 2 / 86 | 21.5× | 3.76e-3 | 3.60e-2 ✓ sig. |
| PIP3 activates AKT signaling | Reactome | 2 / 93 | 19.9× | 4.38e-3 | 4.02e-2 ✓ sig. |
| Endocrine resistance | KEGG | 2 / 99 | 18.7× | 4.95e-3 | 4.36e-2 ✓ sig. |
| Hypertrophic cardiomyopathy | KEGG | 2 / 99 | 18.7× | 4.95e-3 | 4.36e-2 ✓ sig. |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | Reactome | 2 / 103 | 17.9× | 5.34e-3 | 4.57e-2 ✓ sig. |
| MET activates PTPN11 | Reactome | 1 / 5 | 185× | 5.40e-3 | 4.60e-2 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| nucleus organization | GO:0006997 | 3 / 34 | 127× | 1.55e-6 | 1.18e-4 ✓ sig. |
| nuclear membrane organization | GO:0071763 | 2 / 7 | 411× | 9.36e-6 | 4.97e-4 ✓ sig. |
| muscle organ development | GO:0007517 | 3 / 114 | 37.8× | 6.05e-5 | 2.07e-3 ✓ sig. |
| nuclear migration | GO:0007097 | 2 / 22 | 131× | 1.02e-4 | 3.07e-3 ✓ sig. |
| nuclear envelope organization | GO:0006998 | 2 / 24 | 120× | 1.22e-4 | 3.51e-3 ✓ sig. |
| cellular response to gamma radiation | GO:0071480 | 2 / 28 | 103× | 1.67e-4 | 4.44e-3 ✓ sig. |
| determination of adult lifespan | GO:0008340 | 2 / 38 | 75.7× | 3.10e-4 | 6.87e-3 ✓ sig. |
| ephrin receptor signaling pathway | GO:0048013 | 2 / 51 | 56.4× | 5.59e-4 | 1.03e-2 ✓ sig. |
| negative regulation of cation transmembrane transport | GO:1904063 | 1 / 1 | 1,437× | 6.96e-4 | 1.19e-2 ✓ sig. |
| negative regulation of epithelial cell differentiation involved in kidney development | GO:2000697 | 1 / 1 | 1,437× | 6.96e-4 | 1.19e-2 ✓ sig. |
| negative regulation of cortisol secretion | GO:0051463 | 1 / 1 | 1,437× | 6.96e-4 | 1.19e-2 ✓ sig. |
| negative regulation of growth hormone secretion | GO:0060125 | 1 / 1 | 1,437× | 6.96e-4 | 1.19e-2 ✓ sig. |
| intestinal epithelial cell migration | GO:0061582 | 1 / 1 | 1,437× | 6.96e-4 | 1.19e-2 ✓ sig. |
| positive regulation of hydrolase activity | GO:0051345 | 1 / 1 | 1,437× | 6.96e-4 | 1.19e-2 ✓ sig. |
| positive regulation of strand invasion | GO:0098530 | 1 / 1 | 1,437× | 6.96e-4 | 1.19e-2 ✓ sig. |